ArticleBreast cancer research and treatment2017

Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?

Vasileios Askoxylakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.